Search Results - K. Geissler
- Showing 1 - 20 results of 20
-
1
-
2
Murine DX5+NKT Cells Display Their Cytotoxic and Proapoptotic Potentials against Colitis-Inducing CD4+CD62Lhigh T Cells through Fas Ligand by Jens M. Werner, Michael Damian, Stefan A. Farkas, Hans J. Schlitt, Edward K. Geissler, Matthias Hornung
Published in Journal of Immunology Research (2018-01-01)Get full text
Article -
3
Augmenter of Liver Regeneration Reduces Ischemia Reperfusion Injury by Less Chemokine Expression, Gr-1 Infiltration and Oxidative Stress by Thomas S. Weiss, Madeleine Lupke, Rania Dayoub, Edward K. Geissler, Hans J. Schlitt, Michael Melter, Elke Eggenhofer
Published in Cells (2019-11-01)Get full text
Article -
4
Platelet apheresis with additive solution and plasma rinseback affects the cellular composition of LRS chamber products by Katharina Kronenberg, Frauke Dormann, Andreas Brosig, Irene Pamler, Edward K. Geissler, Ralph Burkhardt, Robert Offner, James A. Hutchinson, Viola Haehnel
Published in Scientific Reports (2025-06-01)Get full text
Article -
5
Immunomodulation of Natural Killer Cell Function by Ribavirin Involves TYK-2 Activation and Subsequent Increased IFN-γ Secretion in the Context of In Vitro Hepatitis E Virus Infect... by Paul Kupke, Akinbami Adenugba, Mathias Schemmerer, Florian Bitterer, Hans J. Schlitt, Edward K. Geissler, Jürgen J. Wenzel, Jens M. Werner
Published in Cells (2023-01-01)Get full text
Article -
6
Protective vaccination against papillomavirus-induced skin tumors under immunocompetent and immunosuppressive conditions: a preclinical study using a natural outbred animal model. by Sabrina E Vinzón, Ilona Braspenning-Wesch, Martin Müller, Edward K Geissler, Ingo Nindl, Hermann-Josef Gröne, Kai Schäfer, Frank Rösl
Published in PLoS Pathogens (2014-02-01)Get full text
Article -
7
Cytokine Response of Natural Killer Cells to Hepatitis B Virus Infection Depends on Monocyte Co-Stimulation by Paul Kupke, Johanna Brucker, Jochen M. Wettengel, Ulrike Protzer, Jürgen J. Wenzel, Hans J. Schlitt, Edward K. Geissler, Jens M. Werner
Published in Viruses (2024-05-01)Get full text
Article -
8
Donor-But Not Recipient-Derived Cells Produce Collagen-1 in Chronically Rejected Cardiac Allografts by Saidou Balam, Simone Buchtler, Frederike Winter, Frederike Winter, Kathrin Schmidbauer, Sophia Neumayer, Yvonne Talke, Kerstin Renner, Edward K. Geissler, Matthias Mack, Matthias Mack
Published in Frontiers in Immunology (2022-01-01)Get full text
Article -
9
Extrahepatic Bile Duct Organoids as a Model to Study Ischemia/Reperfusion Injury During Liver Transplantation by P. Kreiner, E. Eggenhofer, L. Schneider, C. Rejas, M. Goetz, N. Bogovic, S. M. Brunner, K. Evert, H. J. Schlitt, E. K. Geissler, H. Junger
Published in Transplant International (2024-09-01)Get full text
Article -
10
Proteolytic shedding of CD46 from human hepatocytes indicates liver stress by Paul Kupke, Jordi Yang Zhou, Gunther Glehr, Paloma Riquelme, Lena Scheibert, Akinbami Adenugba, Hans J. Schlitt, Edward K. Geissler, Jens M. Werner, James A. Hutchinson
Published in Heliyon (2024-12-01)Get full text
Article -
11
Restricting datasets to classifiable samples augments discovery of immune disease biomarkers by Gunther Glehr, Paloma Riquelme, Katharina Kronenberg, Robert Lohmayer, Víctor J. López-Madrona, Michael Kapinsky, Hans J. Schlitt, Edward K. Geissler, Rainer Spang, Sebastian Haferkamp, James A. Hutchinson
Published in Nature Communications (2024-06-01)Get full text
Article -
12
Case report: Predictability of clinical response and rejection risk after immune checkpoint inhibition in liver transplantation by Jordi Yang Zhou, Jordi Yang Zhou, Dominik Eder, Florian Weber, Philipp Heumann, Katharina Kronenberg, Jens M. Werner, Edward K. Geissler, Hans J. Schlitt, James A. Hutchinson, Florian Bitterer
Published in Frontiers in Transplantation (2023-08-01)Get full text
Article -
13
Clinical Use of Tolerogenic Dendritic Cells-Harmonization Approach in European Collaborative Effort by Anja Ten Brinke, Catharien M. U. Hilkens, Nathalie Cools, Edward K. Geissler, James A. Hutchinson, Giovanna Lombardi, Phillip Lord, Birgit Sawitzki, Piotr Trzonkowski, S. Marieke Van Ham, Eva M. Martinez-Caceres
Published in Mediators of Inflammation (2015-01-01)Get full text
Article -
14
External validation of biomarkers for immune-related adverse events after immune checkpoint inhibition by Gunther Glehr, Paloma Riquelme, Jordi Yang Zhou, Jordi Yang Zhou, Laura Cordero, Hannah-Lou Schilling, Michael Kapinsky, Hans J. Schlitt, Edward K. Geissler, Ralph Burkhardt, Barbara Schmidt, Sebastian Haferkamp, James A. Hutchinson, Katharina Kronenberg
Published in Frontiers in Immunology (2022-09-01)Get full text
Article -
15
Soluble CD46 as a diagnostic marker of hepatic steatosisResearch in context by Florian Bitterer, Paul Kupke, Akinbami Adenugba, Katja Evert, Gunther Glehr, Paloma Riquelme, Lena Scheibert, Giulia Preverin, Christina Böhm, Matthias Hornung, Hans J. Schlitt, Jürgen J. Wenzel, Edward K. Geissler, Niloufar Safinia, James A. Hutchinson, Jens M. Werner
Published in EBioMedicine (2024-06-01)Get full text
Article -
16
P573: PHARMACOKINETIC EXPOSURE EQUIVALENCE AND PRELIMINARY EFFICACY AND SAFETY FROM A RANDOMIZED CROSS OVER PHASE 3 STUDY OF AN ORAL HYPOMETHYLATING AGENT DEC-C COMPARED TO IV DECI... by K. Geissler, Z. Koristek, T. Bernal del Castillo, J. Novák, G. Rodriguez Macias, S. K. Metzelder, A. Illes, A. Nagy, J. Mayer, M. Arnan, M.-M. Keating, J. Krauter, M. Lunghi, N. Stefano Fracchiolla, U. Platzbecker, V. Santini, Y. Sano, A. Oganesian, H. Keer, M. Lübbert
Published in HemaSphere (2022-06-01)Get full text
Article -
17
P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PATIENTS WITH RELAPSED INDOLENT NON-HODGKIN LYMPHOMA (NHL): UPDATED SAFETY AND EFFICACY FROM THE PHASE III CHRONOS-3 TRIAL by P. L. Zinzani, M. Özcan, K. Sapunarova, W. Jurczak, A. Hamed, K. Bouabdallah, G. Saydam, K. Geissler, Á. Szomor, M. Lazaroiu, A. Salar, A. Tempescul, M. Nalcaci, L. Gercheva, M. Egyed, P. Panayiotidis, L. Mongay Soler, A. Cao, C. Phelps, B. H Childs, M. J Matasar
Published in HemaSphere (2022-06-01)Get full text
Article -
18
PB1921: A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF TAMIBAROTENE/AZACITIDINE VERSUS PLACEBO/AZACITIDINE IN NEWLY DIAGNOSED ADULT PATIENTS SELECTED FOR RARA-POSITIVE HR-MDS (SELECT... by A. DeZern, G. Marconi, D. Deeren, M. Diez Campelo, M. Lübbert, P. Krishnamurthy, Z. Nagy, G. Basak, A. Jonášová, E. Morozova, K. Geissler, Y. Ofran, H. Kelley, A. Volkert, K. Baker, Q. Kang-Fortner, G. Hodgson, C. Madigan, D. A. Roth, M. Kelly, P. Fenaux
Published in HemaSphere (2022-06-01)Get full text
Article -
19
Novel GM-CSF signals via IFN-γR/IRF-1 and AKT/mTOR license monocytes for suppressor function by Eliana Ribechini, James A. Hutchinson, Sabine Hergovits, Marion Heuer, Jörg Lucas, Ulrike Schleicher, Ana-Laura Jordán Garrote, Sarah J. Potter, Paloma Riquelme, Heike Brackmann, Nora Müller, Hartmann Raifer, Ingolf Berberich, Magdalena Huber, Andreas Beilhack, Michael Lohoff, Christian Bogdan, Matthias Eyrich, Heike M. Hermanns, Edward K. Geissler, Manfred B. Lutz
Published in Blood Advances (2017-06-01)Get full text
Article -
20
Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapies by Phillip Lord, Rachel Spiering, Juan C. Aguillon, Amy E. Anderson, Silke Appel, Daniel Benitez-Ribas, Anja ten Brinke, Femke Broere, Nathalie Cools, Maria Cristina Cuturi, Julie Diboll, Edward K. Geissler, Nick Giannoukakis, Silvia Gregori, S. Marieke van Ham, Staci Lattimer, Lindsay Marshall, Rachel A. Harry, James A. Hutchinson, John D. Isaacs, Irma Joosten, Cees van Kooten, Ascension Lopez Diaz de Cerio, Tatjana Nikolic, Haluk Barbaros Oral, Ljiljana Sofronic-Milosavljevic, Thomas Ritter, Paloma Riquelme, Angus W. Thomson, Massimo Trucco, Marta Vives-Pi, Eva M. Martinez-Caceres, Catharien M.U. Hilkens
Published in PeerJ (2016-08-01)Get full text
Article
